A Study of the Safety, Tolerance, & Pharmacokinetics of Oral Posaconazole

Updated 05/03/2024

Status Terminated

Clinical Trial Summary

The purpose of this dose-escalation study is to evaluate the pharmacokinetics, safety, and tolerability of oral posaconazole in immunocompromised children with neutropenia or expected neutropenia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01716234
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Terminated
Phase	Phase 1
Start date	April 17, 2008
Completion date	April 1, 2015

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01782131` - A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)	Phase 3
	Completed	`NCT02631954` - Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers	Phase 1
	Completed	`NCT00177684` - Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)	Phase 3
	Recruiting	`NCT01684189` - Registry of Febrile Neutropenia and Invasive Fungal Infections	N/A
	Completed	`NCT00794703` - A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections	Phase 3
	Completed	`NCT00606268` - A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant	Phase 1
	Completed	`NCT00353158` - A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity	Phase 1
	Completed	`NCT01777763` - Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)	Phase 1
	Recruiting	`NCT01222741` - Studies of Disorders With Increased Susceptibility to Fungal Infections
	Completed	`NCT02358499` - Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children	Phase 1
	Completed	`NCT00177710` - Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study	Phase 3
	Enrolling by invitation	`NCT03793231` - fungalAi for Fungal Surveillance & Antifungal Stewardship
	Completed	`NCT02025699` - Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis	N/A
	Completed	`NCT01436578` - Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)	N/A
	Completed	`NCT00876096` - Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections	N/A
	Completed	`NCT02306330` - MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial	N/A
	Not yet recruiting	`NCT01105013` - Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections	Phase 3
	Recruiting	`NCT05336851` - Emergency PWAS in Respiratory Infectious Disease